Search

Author/Creator Al-Rajabi, R

1. 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. (17th December 2018)

Authors:
He, A R; Weiss, G J; Falchook, G; Yee, N S; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; Pishvaian, M J; Stankevich, E; Feng, M; Li, J; Mathias, M; Kroog, G; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1151PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study. (23rd October 2018)

Authors:
Pishvaian, M J; Weiss, G J; Falchook, G S; Yee, N; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; Stankevich, E; Feng, M; Li, J; Mathias, M; Kroog, G; Lowy, I; Fury, M G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search